Pharmacists in Red Oak, Texas


14 Pharmacists found in Red Oak
male pharmacist

Ali Hyder Syed


Pharmacist
105 Harris Ave, Red Oak, TX 75154
972-617-0034    

female pharmacist

Brenda Rene Quintana, PHD


Pharmacist
105 Harris Ave, Red Oak, TX 75154
972-617-0034     972-576-4858

male pharmacist

Dennis Weiting Chen


Pharmacist
105 Harris Ave, Red Oak, TX 75154
972-617-0034    



male pharmacist

Henry Thomas Knudson, PHARMD


Pharmacist
100 S Ryan Dr, Red Oak, TX 75154
972-515-2066    

male pharmacist

John Shawn Piper, RPH


Pharmacist
105 E Ovilla Rd, Red Oak, TX 75154
972-617-8570     972-617-8571

female pharmacist

Kelli Dulaney


Pharmacist
100 S Ryan Dr, Red Oak, TX 75154
972-515-2066    

male pharmacist

Matthew Tran, PHARMD


Pharmacist
105 Harris Ave, Red Oak, TX 75154
972-617-0034    

female pharmacist

Maureen Evelyn Walme-brown, PHARMD


Pharmacist
100 S Ryan Dr, Red Oak, TX 75154
972-515-2066     972-515-2063

female pharmacist

Oluwadamilola Ayanda


Pharmacist
105 Harris Ave, Red Oak, TX 75154
972-617-0034    

male pharmacist

Dr. Osinachi Nwachukwu Obasi


Pharmacist
105 Harris Ave, Red Oak, TX 75154
469-636-8063    

male pharmacist

Dr. Shane Malekouti


Pharmacist
107 E Ovilla Rd, Red Oak, TX 75154
972-576-3301    

female pharmacist

Tiffany Do


Pharmacist
Apex Health, 505 N Interstate 35, Red Oak, TX 75154
469-820-3460    

male pharmacist

Dr. Vu Uy Nguyen, PHARMD


Pharmacist
100 S Ryan Dr, Red Oak, TX 75154
972-515-2066     972-515-2063

male pharmacist

Dr. Yonas Churuko Kolaso, PHARMD


Pharmacist
107 E Ovilla Rd, Red Oak, TX 75154
972-576-3303    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.